CircRNA ZNF609 Knockdown Represses the Development of Non-Small Cell Lung Cancer via miR-623/FOXM1 Axis

References

• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640. doi:10.1016/j.mayocp.2019.01.01331378236
   PubMed Web of Science ®Google Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15(8):995–1005.29954251
   PubMed Web of Science ®Google Scholar
• Zhang C, Ma L, Niu Y, et al. Circular RNA in Lung Cancer Research: biogenesis, Functions, and Roles. Int J Biol Sci. 2020;16(5):803–814.32071550
   PubMed Web of Science ®Google Scholar
• Li C, Zhang L, Meng G, et al. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J Cancer Res Clin Oncol. 2019;145(12):2875–2889.31630262
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234(7):10646–10654.30478938
   PubMed Web of Science ®Google Scholar
• Wang S, Xue X, Wang R, et al. CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p. Cancer Manag Res. 2018;10:(3881–3890.
   Web of Science ®Google Scholar
• Zhu L, Liu Y, Yang Y, et al. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci. 2019;23(7):2817–2826.31002133
   PubMed Web of Science ®Google Scholar
• Jin X, Guan Y, Sheng H, et al. Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer. Oncotarget. 2017;8(53):91270–91280.29207642
   PubMedGoogle Scholar
• Zhou Q, Huang S-X, Zhang F, et al. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Cell Prolif. 2017;50(6):54. doi:10.1111/cpr.12394
   Web of Science ®Google Scholar
• Jiang L, Yang W, Bian W, et al. MicroRNA-623 targets cyclin d1 to inhibit cell proliferation and enhance the chemosensitivity of cells to 5-fluorouracil in gastric cancer. Oncol Res. 2018;27(1):19–27. doi:10.3727/096504018X1519346924050829495973
   PubMed Web of Science ®Google Scholar
• Chen Y, Peng S, Cen H, et al. MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer. Int J Oncol. 2019;55(1):142–156. doi:10.3892/ijo.2019.480331115512
   PubMed Web of Science ®Google Scholar
• Ren F, Su H, Jiang H, et al. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5. J Cell Biochem. 2020;121(1):213–223. doi:10.1002/jcb.2911731190447
   PubMed Web of Science ®Google Scholar
• Wei S, Zhang Z-Y, Fu S-L, et al. RETRACTED ARTICLE: hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma. Cell Death Dis. 2016;7(9):e2388. doi:10.1038/cddis.2016.26027685632
   PubMed Web of Science ®Google Scholar
• Gartel AL. FOXM1 in Cancer: interactions and Vulnerabilities. Cancer Res. 2017;77(12):3135–3139. doi:10.1158/0008-5472.CAN-16-356628584182
   PubMed Web of Science ®Google Scholar
• Li Y, Wu F, Tan Q, et al. The multifaceted roles of FOXM1 in pulmonary disease. Cell Commun Signal. 2019;17(1):35. doi:10.1186/s12964-019-0347-130992007
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang J, Cui X, et al. FoxM1: a novel tumor biomarker of lung cancer. Int J Clin Exp Med. 2015;8(3):3136–3140.26064203
   PubMed Web of Science ®Google Scholar
• Liu B, Su F, Lin R, et al. Overexpression of forkhead box M1 is associated poor survival in patients with nonsmall cell lung cancer. J Cancer Res Ther. 2018;14(7):S1121–S1123. doi:10.4103/0973-1482.20360530539856
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Du X, et al. <p>MiR-216b suppresses cell proliferation, migration, invasion, and epithelial–mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer. Onco Targets Ther. 2019;12:(2999–3009. doi:10.2147/OTT.S202523
   Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on. Nat Protoc. 2006;1(2):581–585. doi:10.1038/nprot.2006.8317406285
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Balata H, Fong KM, Hendriks LE, et al. Prevention and Early Detection for NSCLC: advances in Thoracic Oncology 2018. J Thorac Oncol. 2019;14(9):1513–1527. doi:10.1016/j.jtho.2019.06.01131228621
   PubMed Web of Science ®Google Scholar
• Drula R, Braicu C, Harangus A, et al. Critical function of circular RNAs in lung cancer. Wiley Interdiscip Rev RNA. 2020;11(5):e1592. doi:10.1002/wrna.159232180372
   PubMed Web of Science ®Google Scholar
• Hu W, Bi Z-Y, Chen Z-L, et al. Emerging landscape of circular RNAs in lung cancer. Cancer Lett. 2018;427:(18–27. doi:10.1016/j.canlet.2018.04.006
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qiao WB, Shan L. Expression and functional characterization of FOXM1 in non-small cell lung cancer. Onco Targets Ther. 2018;11:(3385–3393.
   Web of Science ®Google Scholar
• Li R, Wang X, Zhao X, et al. Centromere protein F and Forkhead box M1 correlation with prognosis of non-small cell lung cancer. Oncol Lett. 2020;19(2):1368–1374.31966068
   PubMed Web of Science ®Google Scholar
• Integrated Network AF. Analysis Reveals FOXM1 and MYBL2 as key regulators of cell proliferation in non-small cell lung cancer. Front Oncol. 2019;9:(1011.
   Web of Science ®Google Scholar
• Zhao L, Liu L, Dong Z, et al. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis. Oncol Rep. 2017;38(6):3522–3530.29130108
   PubMed Web of Science ®Google Scholar
• Yuan Y, Haiying G, Zhuo L, et al. Long non-coding RNA LINC00339 facilitates the tumorigenesis of non-small cell lung cancer by sponging miR-145 through targeting FOXM1. Biomed Pharmacother. 2018;105:(707–713.
   Web of Science ®Google Scholar
• Langdon SP. Animal modeling of cancer pathology and studying tumor response to therapy. Curr Drug Targets. 2012;13(12):1535–1547.22974396
   PubMed Web of Science ®Google Scholar
• Singh AP, Adrianzen Herrera D, Zhang Y, et al. Mouse models in squamous cell lung cancer: impact for drug discovery. Expert Opin Drug Discov. 2018;13(4):347–358.29394493
   PubMed Web of Science ®Google Scholar